Because BCL2L1 has not been previously characterized as a driver oncogene in breast cancer, we used the TCGA cell line database (http://www.cbioportal.org/) to identify an additional breast cancer cell line, HCC38, which also harbors a focal amplification of BCL2L1. Here, BCL2L1 is linked to breast carcinoma.